I think pretty much...for a price of course. 10 million for the products, we will see if it's a good deal. I think Novel asset plays into this as well. 30 million for Novel and it won't be a problem.
(0)
(0)
Elite Pharmaceuticals Inc (ELTP) Stock Research Links
